Please provide your email address to receive an email when new articles are posted on . The FDA has designated a recall of a peripheral catheter system as class I, the most serious kind. Teleflex and ...

Future research should focus on testing PVC removal beyond 96 hours, patient preferences for routine or clinically indicated PVC removal, more rigorous studies and use of ultrasound to assess PVC ...

The Peripheral IV Catheters Market stands as a testament to this axiom, poised to achieve remarkable growth, with an estimated value of $6,027 million by 2024. Fuelled by a robust compound annual ...

To report the experience of peripheral insertion of double-lumen central catheters (PIDLCC) in preterm and term newborn infants and to analyze the technical characteristics of the procedure and any ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a global provider of medical devices for critical care and surgery, announced today that its ARROW Endurance™ Extended Dwell Peripheral ...

More than one in 10 catheter-related bloodstream infections due to S. aureus in hospitalized adults are caused by infected peripheral venous catheters, according to new research. The study points out ...

Teleflex Incorporated (NYSE:TFX) and its subsidiary Arrow International are recalling the ARROW Endurance Extended Dwell Peripheral Catheter System after reports of catheter separation or leakage. The ...

The case report by Vasquez et al. 1 describing the treatment of peripheral artery catheter-induced ischemic injury with topical nitroglycerin ointment in a newborn infant was interesting. Although the ...

New York, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Peripheral IV Catheters Global Market Report 2022" - https://www ...

A new study from Rhode Island Hospital has found that more than one in 10 catheter-related bloodstream infections due to Staph aureus in hospitalized adults are caused by infected peripheral venous ...